ID DPYD_PIG Reviewed; 1025 AA. AC Q28943; DT 01-NOV-1997, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1997, sequence version 1. DT 27-MAR-2024, entry version 155. DE RecName: Full=Dihydropyrimidine dehydrogenase [NADP(+)] {ECO:0000305}; DE Short=DHPDHase; DE Short=DPD; DE EC=1.3.1.2 {ECO:0000269|PubMed:20831907, ECO:0000269|PubMed:8083224, ECO:0000269|PubMed:9860876}; DE AltName: Full=Dihydrothymine dehydrogenase; DE AltName: Full=Dihydrouracil dehydrogenase; DE Flags: Precursor; GN Name=DPYD; OS Sus scrofa (Pig). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Laurasiatheria; Artiodactyla; Suina; Suidae; Sus. OX NCBI_TaxID=9823; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, AND CATALYTIC RP ACTIVITY. RC TISSUE=Liver; RX PubMed=8083224; DOI=10.1016/s0021-9258(17)31638-1; RA Yokota H., Fernandez-Salguero P., Furuya H., Lin K., McBride O.W., RA Podschun B., Schnackerz K.D., Gonzalez F.J.; RT "cDNA cloning and chromosome mapping of human dihydropyrimidine RT dehydrogenase, an enzyme associated with 5-fluorouracil toxicity and RT congenital thymine uraciluria."; RL J. Biol. Chem. 269:23192-23196(1994). RN [2] RP FUNCTION, CATALYTIC ACTIVITY, SUBUNIT, COFACTOR, AND MUTAGENESIS OF RP CYS-671. RX PubMed=9860876; DOI=10.1021/bi9815997; RA Rosenbaum K., Jahnke K., Curti B., Hagen W.R., Schnackerz K.D., RA Vanoni M.A.; RT "Porcine recombinant dihydropyrimidine dehydrogenase: comparison of the RT spectroscopic and catalytic properties of the wild-type and C671A mutant RT enzymes."; RL Biochemistry 37:17598-17609(1998). RN [3] RP FUNCTION, CATALYTIC ACTIVITY, COFACTOR, AND MUTAGENESIS OF CYS-126; RP GLN-156; ARG-235 AND SER-670. RX PubMed=20831907; DOI=10.1016/j.bbapap.2010.08.014; RA Lohkamp B., Voevodskaya N., Lindqvist Y., Dobritzsch D.; RT "Insights into the mechanism of dihydropyrimidine dehydrogenase from site- RT directed mutagenesis targeting the active site loop and redox cofactor RT coordination."; RL Biochim. Biophys. Acta 1804:2198-2206(2010). RN [4] RP X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) IN COMPLEXES WITH 5-FLUOROURACIL; RP FAD; FMN; 4FE-4S IRON-SULFUR CLUSTER AND NADP, FUNCTION, SUBUNIT, AND RP COFACTOR. RX PubMed=11179210; DOI=10.1093/emboj/20.4.650; RA Dobritzsch D., Schneider G., Schnackerz K.D., Lindqvist Y.; RT "Crystal structure of dihydropyrimidine dehydrogenase, a major determinant RT of the pharmacokinetics of the anti-cancer drug 5-fluorouracil."; RL EMBO J. 20:650-660(2001). RN [5] RP X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) IN COMPLEX WITH 5-IODOURACIL; FAD; RP FMN; 4FE-4S IRON-SULFUR CLUSTER AND NADP, COFACTOR, AND ACTIVE SITE. RX PubMed=11796730; DOI=10.1074/jbc.m111877200; RA Dobritzsch D., Ricagno S., Schneider G., Schnackerz K.D., Lindqvist Y.; RT "Crystal structure of the productive ternary complex of dihydropyrimidine RT dehydrogenase with NADPH and 5-iodouracil. Implications for mechanism of RT inhibition and electron transfer."; RL J. Biol. Chem. 277:13155-13166(2002). CC -!- FUNCTION: Involved in pyrimidine base degradation. Catalyzes the CC reduction of uracil and thymine. {ECO:0000269|PubMed:11179210, CC ECO:0000269|PubMed:20831907, ECO:0000269|PubMed:9860876}. CC -!- CATALYTIC ACTIVITY: CC Reaction=5,6-dihydrouracil + NADP(+) = H(+) + NADPH + uracil; CC Xref=Rhea:RHEA:18093, ChEBI:CHEBI:15378, ChEBI:CHEBI:15901, CC ChEBI:CHEBI:17568, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.3.1.2; CC Evidence={ECO:0000269|PubMed:20831907, ECO:0000269|PubMed:8083224, CC ECO:0000269|PubMed:9860876}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:18095; CC Evidence={ECO:0000269|PubMed:8083224}; CC -!- CATALYTIC ACTIVITY: CC Reaction=5,6-dihydrothymine + NADP(+) = H(+) + NADPH + thymine; CC Xref=Rhea:RHEA:58284, ChEBI:CHEBI:15378, ChEBI:CHEBI:17821, CC ChEBI:CHEBI:27468, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.3.1.2; CC Evidence={ECO:0000269|PubMed:8083224}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:58286; CC Evidence={ECO:0000305|PubMed:8083224}; CC -!- COFACTOR: CC Name=FAD; Xref=ChEBI:CHEBI:57692; CC Note=Binds 2 FAD. {ECO:0000269|PubMed:11796730}; CC -!- COFACTOR: CC Name=FMN; Xref=ChEBI:CHEBI:58210; CC Note=Binds 2 FMN. {ECO:0000269|PubMed:11796730}; CC -!- COFACTOR: CC Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883; CC Note=Binds 4 [4Fe-4S] clusters. Contains approximately 16 iron atoms CC per subunit. {ECO:0000269|PubMed:11796730}; CC -!- ACTIVITY REGULATION: Inactivated by 5-iodouracil. CC {ECO:0000269|PubMed:11796730}. CC -!- PATHWAY: Amino-acid biosynthesis; beta-alanine biosynthesis. CC {ECO:0000305|PubMed:8083224}. CC -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:11179210, CC ECO:0000269|PubMed:11796730, ECO:0000269|PubMed:9860876}. CC -!- SUBCELLULAR LOCATION: Cytoplasm. CC -!- SIMILARITY: Belongs to the dihydropyrimidine dehydrogenase family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; U09179; AAA57475.1; -; mRNA. DR PIR; B54718; B54718. DR RefSeq; NP_999209.1; NM_214044.2. DR PDB; 1GT8; X-ray; 3.30 A; A/B/C/D=1-1025. DR PDB; 1GTE; X-ray; 1.65 A; A/B/C/D=1-1025. DR PDB; 1GTH; X-ray; 2.25 A; A/B/C/D=1-1025. DR PDB; 1H7W; X-ray; 1.90 A; A/B/C/D=1-1025. DR PDB; 1H7X; X-ray; 2.01 A; A/B/C/D=1-1025. DR PDB; 7LJS; X-ray; 2.00 A; A/B/C/D=1-1025. DR PDB; 7LJT; X-ray; 1.98 A; A/B/C/D=1-1025. DR PDB; 7LJU; X-ray; 1.87 A; A/B/C/D=1-1025. DR PDB; 7M31; X-ray; 1.69 A; A/B/C/D=1-1025. DR PDB; 7M32; X-ray; 1.82 A; A/B/C/D=1-1025. DR PDB; 8F5W; X-ray; 1.97 A; A/B/C/D=1-1025. DR PDB; 8F61; X-ray; 2.14 A; A/B/C/D=1-1025. DR PDB; 8F6N; X-ray; 2.12 A; A/B/C/D=1-1018. DR PDBsum; 1GT8; -. DR PDBsum; 1GTE; -. DR PDBsum; 1GTH; -. DR PDBsum; 1H7W; -. DR PDBsum; 1H7X; -. DR PDBsum; 7LJS; -. DR PDBsum; 7LJT; -. DR PDBsum; 7LJU; -. DR PDBsum; 7M31; -. DR PDBsum; 7M32; -. DR PDBsum; 8F5W; -. DR PDBsum; 8F61; -. DR PDBsum; 8F6N; -. DR AlphaFoldDB; Q28943; -. DR SMR; Q28943; -. DR STRING; 9823.ENSSSCP00000007333; -. DR PaxDb; 9823-ENSSSCP00000007333; -. DR PeptideAtlas; Q28943; -. DR GeneID; 397109; -. DR KEGG; ssc:397109; -. DR CTD; 1806; -. DR eggNOG; KOG1799; Eukaryota. DR InParanoid; Q28943; -. DR OrthoDB; 1211169at2759; -. DR BRENDA; 1.3.1.2; 6170. DR UniPathway; UPA00131; -. DR EvolutionaryTrace; Q28943; -. DR Proteomes; UP000008227; Unplaced. DR Proteomes; UP000314985; Unplaced. DR Proteomes; UP000694570; Unplaced. DR Proteomes; UP000694571; Unplaced. DR Proteomes; UP000694720; Unplaced. DR Proteomes; UP000694722; Unplaced. DR Proteomes; UP000694723; Unplaced. DR Proteomes; UP000694724; Unplaced. DR Proteomes; UP000694725; Unplaced. DR Proteomes; UP000694726; Unplaced. DR Proteomes; UP000694727; Unplaced. DR Proteomes; UP000694728; Unplaced. DR GO; GO:0005737; C:cytoplasm; ISS:UniProtKB. DR GO; GO:0005829; C:cytosol; IBA:GO_Central. DR GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW. DR GO; GO:0017113; F:dihydropyrimidine dehydrogenase (NADP+) activity; IDA:UniProtKB. DR GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB. DR GO; GO:0010181; F:FMN binding; IDA:UniProtKB. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0050661; F:NADP binding; IDA:UniProtKB. DR GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB. DR GO; GO:0002058; F:uracil binding; IBA:GO_Central. DR GO; GO:0019483; P:beta-alanine biosynthetic process; IEA:UniProtKB-UniPathway. DR GO; GO:0006214; P:thymidine catabolic process; ISS:UniProtKB. DR GO; GO:0006210; P:thymine catabolic process; IBA:GO_Central. DR GO; GO:0006212; P:uracil catabolic process; ISS:UniProtKB. DR CDD; cd02940; DHPD_FMN; 1. DR Gene3D; 3.30.70.20; -; 1. DR Gene3D; 3.20.20.70; Aldolase class I; 1. DR Gene3D; 1.10.1060.10; Alpha-helical ferredoxin; 1. DR Gene3D; 3.50.50.60; FAD/NAD(P)-binding domain; 2. DR InterPro; IPR017896; 4Fe4S_Fe-S-bd. DR InterPro; IPR017900; 4Fe4S_Fe_S_CS. DR InterPro; IPR013785; Aldolase_TIM. DR InterPro; IPR005720; Dihydroorotate_DH_cat. DR InterPro; IPR028261; DPD_II. DR InterPro; IPR036188; FAD/NAD-bd_sf. DR InterPro; IPR023753; FAD/NAD-binding_dom. DR InterPro; IPR009051; Helical_ferredxn. DR PANTHER; PTHR43073; DIHYDROPYRIMIDINE DEHYDROGENASE [NADP(+)]; 1. DR PANTHER; PTHR43073:SF2; DIHYDROPYRIMIDINE DEHYDROGENASE [NADP(+)]; 1. DR Pfam; PF01180; DHO_dh; 1. DR Pfam; PF14691; Fer4_20; 1. DR Pfam; PF14697; Fer4_21; 1. DR Pfam; PF07992; Pyr_redox_2; 1. DR PRINTS; PR00419; ADXRDTASE. DR SUPFAM; SSF54862; 4Fe-4S ferredoxins; 1. DR SUPFAM; SSF46548; alpha-helical ferredoxin; 1. DR SUPFAM; SSF51395; FMN-linked oxidoreductases; 1. DR SUPFAM; SSF51971; Nucleotide-binding domain; 2. DR PROSITE; PS00198; 4FE4S_FER_1; 1. DR PROSITE; PS51379; 4FE4S_FER_2; 3. PE 1: Evidence at protein level; KW 3D-structure; 4Fe-4S; Acetylation; Cytoplasm; Direct protein sequencing; KW FAD; Flavoprotein; FMN; Iron; Iron-sulfur; Metal-binding; NADP; KW Nucleotide-binding; Oxidoreductase; Reference proteome; Repeat. FT PROPEP 1..3 FT /id="PRO_0000021116" FT CHAIN 4..1025 FT /note="Dihydropyrimidine dehydrogenase [NADP(+)]" FT /id="PRO_0000021117" FT DOMAIN 69..100 FT /note="4Fe-4S ferredoxin-type 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00711" FT DOMAIN 944..976 FT /note="4Fe-4S ferredoxin-type 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00711" FT DOMAIN 978..1007 FT /note="4Fe-4S ferredoxin-type 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00711" FT ACT_SITE 671 FT /note="Proton acceptor" FT /evidence="ECO:0000269|PubMed:11796730" FT BINDING 79 FT /ligand="[4Fe-4S] cluster" FT /ligand_id="ChEBI:CHEBI:49883" FT /ligand_label="1" FT BINDING 82 FT /ligand="[4Fe-4S] cluster" FT /ligand_id="ChEBI:CHEBI:49883" FT /ligand_label="1" FT BINDING 87 FT /ligand="[4Fe-4S] cluster" FT /ligand_id="ChEBI:CHEBI:49883" FT /ligand_label="1" FT BINDING 91 FT /ligand="[4Fe-4S] cluster" FT /ligand_id="ChEBI:CHEBI:49883" FT /ligand_label="2" FT BINDING 129 FT /ligand="FAD" FT /ligand_id="ChEBI:CHEBI:57692" FT /evidence="ECO:0000269|PubMed:11796730" FT BINDING 130 FT /ligand="[4Fe-4S] cluster" FT /ligand_id="ChEBI:CHEBI:49883" FT /ligand_label="2" FT BINDING 136 FT /ligand="[4Fe-4S] cluster" FT /ligand_id="ChEBI:CHEBI:49883" FT /ligand_label="2" FT BINDING 140 FT /ligand="[4Fe-4S] cluster" FT /ligand_id="ChEBI:CHEBI:49883" FT /ligand_label="1" FT BINDING 156 FT /ligand="[4Fe-4S] cluster" FT /ligand_id="ChEBI:CHEBI:49883" FT /ligand_label="2" FT BINDING 194..198 FT /ligand="FAD" FT /ligand_id="ChEBI:CHEBI:57692" FT /evidence="ECO:0000269|PubMed:11796730" FT BINDING 218..226 FT /ligand="FAD" FT /ligand_id="ChEBI:CHEBI:57692" FT /evidence="ECO:0000269|PubMed:11796730" FT BINDING 235 FT /ligand="FAD" FT /ligand_id="ChEBI:CHEBI:57692" FT /evidence="ECO:0000269|PubMed:11796730" FT BINDING 261 FT /ligand="FAD" FT /ligand_id="ChEBI:CHEBI:57692" FT /evidence="ECO:0000269|PubMed:11796730" FT BINDING 340..343 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000269|PubMed:11796730" FT BINDING 364..365 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000269|PubMed:11796730" FT BINDING 371 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000269|PubMed:11796730" FT BINDING 437..439 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000269|PubMed:11796730" FT BINDING 480..489 FT /ligand="FAD" FT /ligand_id="ChEBI:CHEBI:57692" FT /evidence="ECO:0000269|PubMed:11796730" FT BINDING 481..487 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000269|PubMed:11796730" FT BINDING 550 FT /ligand="FMN" FT /ligand_id="ChEBI:CHEBI:58210" FT /evidence="ECO:0000269|PubMed:11796730" FT BINDING 574..575 FT /ligand="FMN" FT /ligand_id="ChEBI:CHEBI:58210" FT /evidence="ECO:0000269|PubMed:11796730" FT BINDING 609 FT /ligand="substrate" FT BINDING 668..670 FT /ligand="substrate" FT BINDING 709 FT /ligand="FMN" FT /ligand_id="ChEBI:CHEBI:58210" FT /evidence="ECO:0000269|PubMed:11796730" FT BINDING 736..737 FT /ligand="substrate" FT BINDING 767 FT /ligand="FMN" FT /ligand_id="ChEBI:CHEBI:58210" FT /evidence="ECO:0000269|PubMed:11796730" FT BINDING 793..795 FT /ligand="FMN" FT /ligand_id="ChEBI:CHEBI:58210" FT /evidence="ECO:0000269|PubMed:11796730" FT BINDING 816..817 FT /ligand="FMN" FT /ligand_id="ChEBI:CHEBI:58210" FT /evidence="ECO:0000269|PubMed:11796730" FT BINDING 953 FT /ligand="[4Fe-4S] cluster" FT /ligand_id="ChEBI:CHEBI:49883" FT /ligand_label="3" FT BINDING 956 FT /ligand="[4Fe-4S] cluster" FT /ligand_id="ChEBI:CHEBI:49883" FT /ligand_label="3" FT BINDING 959 FT /ligand="[4Fe-4S] cluster" FT /ligand_id="ChEBI:CHEBI:49883" FT /ligand_label="3" FT BINDING 963 FT /ligand="[4Fe-4S] cluster" FT /ligand_id="ChEBI:CHEBI:49883" FT /ligand_label="3" FT BINDING 986 FT /ligand="[4Fe-4S] cluster" FT /ligand_id="ChEBI:CHEBI:49883" FT /ligand_label="4" FT BINDING 989 FT /ligand="[4Fe-4S] cluster" FT /ligand_id="ChEBI:CHEBI:49883" FT /ligand_label="4" FT BINDING 992 FT /ligand="[4Fe-4S] cluster" FT /ligand_id="ChEBI:CHEBI:49883" FT /ligand_label="4" FT BINDING 996 FT /ligand="[4Fe-4S] cluster" FT /ligand_id="ChEBI:CHEBI:49883" FT /ligand_label="4" FT MOD_RES 384 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:Q12882" FT MUTAGEN 126 FT /note="C->A: No effect on enzyme activity. Reduced iron FT content." FT /evidence="ECO:0000269|PubMed:20831907" FT MUTAGEN 156 FT /note="Q->E: Loss of enzyme activity. Reduces iron FT content." FT /evidence="ECO:0000269|PubMed:20831907" FT MUTAGEN 235 FT /note="R->A,K: Loss of enzyme activity. Loss of FAD FT binding." FT /evidence="ECO:0000269|PubMed:20831907" FT MUTAGEN 670 FT /note="S->A: Strongly reduced affinity for uracil. Reduces FT enzyme activity by 30%." FT /evidence="ECO:0000269|PubMed:20831907" FT MUTAGEN 671 FT /note="C->A: Reduces catalytic activity by 99%." FT /evidence="ECO:0000269|PubMed:9860876" FT MUTAGEN 673 FT /note="H->Q: Reduces activity by 50%." FT HELIX 10..15 FT /evidence="ECO:0007829|PDB:1GTE" FT TURN 16..18 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 24..26 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 31..41 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 69..78 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 86..89 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 97..105 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 109..119 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 123..129 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 132..134 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 136..139 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 141..144 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 145..147 FT /evidence="ECO:0007829|PDB:8F6N" FT HELIX 152..166 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 179..181 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 184..187 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 190..193 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 197..208 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 214..222 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 226..229 FT /evidence="ECO:0007829|PDB:1GTE" FT TURN 233..235 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 238..249 FT /evidence="ECO:0007829|PDB:1GTE" FT TURN 250..252 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 254..258 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 268..273 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 278..281 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 292..294 FT /evidence="ECO:0007829|PDB:1GTE" FT TURN 299..302 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 303..305 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 306..317 FT /evidence="ECO:0007829|PDB:1GTE" FT TURN 319..321 FT /evidence="ECO:0007829|PDB:8F5W" FT STRAND 322..324 FT /evidence="ECO:0007829|PDB:1H7X" FT STRAND 333..338 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 342..353 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 357..362 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 367..369 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 374..382 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 386..388 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 390..399 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 402..413 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 415..417 FT /evidence="ECO:0007829|PDB:8F5W" FT STRAND 419..430 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 432..436 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 445..450 FT /evidence="ECO:0007829|PDB:1GTE" FT TURN 451..453 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 460..462 FT /evidence="ECO:0007829|PDB:1GTE" FT TURN 466..468 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 476..478 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 481..483 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 489..510 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 527..530 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 535..537 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 540..548 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 552..554 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 557..566 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 569..572 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 579..581 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 590..592 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 601..603 FT /evidence="ECO:0007829|PDB:7LJT" FT STRAND 607..609 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 618..631 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 635..641 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 647..659 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 663..668 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 676..678 FT /evidence="ECO:0007829|PDB:7M31" FT HELIX 684..686 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 688..701 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 706..710 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 717..727 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 730..734 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 738..740 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 750..752 FT /evidence="ECO:0007829|PDB:1GTE" FT TURN 755..758 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 763..767 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 768..770 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 771..784 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 790..795 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 799..807 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 811..816 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 817..820 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 826..840 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 844..846 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 848..850 FT /evidence="ECO:0007829|PDB:1GT8" FT STRAND 858..860 FT /evidence="ECO:0007829|PDB:8F5W" FT TURN 869..873 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 880..899 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 921..924 FT /evidence="ECO:0007829|PDB:1GTE" FT TURN 925..928 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 929..931 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 935..937 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 940..942 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 944..948 FT /evidence="ECO:0007829|PDB:1GTE" FT TURN 950..952 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 958..966 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 971..973 FT /evidence="ECO:0007829|PDB:1GTE" FT TURN 975..977 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 980..982 FT /evidence="ECO:0007829|PDB:1GTE" FT HELIX 991..995 FT /evidence="ECO:0007829|PDB:1GTE" FT TURN 999..1001 FT /evidence="ECO:0007829|PDB:1GTE" FT STRAND 1002..1006 FT /evidence="ECO:0007829|PDB:1GTE" SQ SEQUENCE 1025 AA; 111424 MW; B8D553AD862845D0 CRC64; MAPVLSKDVA DIESILALNP RTQSHAALHS TLAKKLDKKH WKRNPDKNCF HCEKLENNFG DIKHTTLGER GALREAMRCL KCADAPCQKS CPTHLDIKSF ITSISNKNYY GAAKMIFSDN PLGLTCGMVC PTSDLCVGGC NLYATEEGSI NIGGLQQFAS EVFKAMNIPQ IRNPCLPSQE KMPEAYSAKI ALLGAGPASI SCASFLARLG YSDITIFEKQ EYVGGLSTSE IPQFRLPYDV VNFEIELMKD LGVKIICGKS LSENEITLNT LKEEGYKAAF IGIGLPEPKT DDIFQGLTQD QGFYTSKDFL PLVAKSSKAG MCACHSPLPS IRGAVIVLGA GDTAFDCATS ALRCGARRVF LVFRKGFVNI RAVPEEVELA KEEKCEFLPF LSPRKVIVKG GRIVAVQFVR TEQDETGKWN EDEDQIVHLK ADVVISAFGS VLRDPKVKEA LSPIKFNRWD LPEVDPETMQ TSEPWVFAGG DIVGMANTTV ESVNDGKQAS WYIHKYIQAQ YGASVSAKPE LPLFYTPVDL VDISVEMAGL KFINPFGLAS AAPTTSSSMI RRAFEAGWGF ALTKTFSLDK DIVTNVSPRI VRGTTSGPMY GPGQSSFLNI ELISEKTAAY WCQSVTELKA DFPDNIVIAS IMCSYNKNDW MELSRKAEAS GADALELNLS CPHGMGERGM GLACGQDPEL VRNICRWVRQ AVQIPFFAKL TPNVTDIVSI ARAAKEGGAD GVTATNTVSG LMGLKADGTP WPAVGAGKRT TYGGVSGTAI RPIALRAVTT IARALPGFPI LATGGIDSAE SGLQFLHSGA SVLQVCSAVQ NQDFTVIQDY CTGLKALLYL KSIEELQGWD GQSPGTESHQ KGKPVPRIAE LMGKKLPNFG PYLEQRKKII AEEKMRLKEQ NAAFPPLERK PFIPKKPIPA IKDVIGKALQ YLGTFGELSN IEQVVAVIDE EMCINCGKCY MTCNDSGYQA IQFDPETHLP TVTDTCTGCT LCLSVCPIID CIRMVSRTTP YEPKRGLPLA VNPVC //